Tandogdu, Zafer http://orcid.org/0000-0002-5309-3656
Koves, Bela
Ristovski, Slobodan
Balci, Mustafa Bahadir Can
Rennesund, Kristin
Gravas, Stavros
Nale, DjordJe
Medina-Polo, José
Garabášová, Mária Kopilec
Costantini, Elisabetta
Cano-Valasco, Jorge
Glavinova, Maja Sofronievska
Bruyere, Franck
Perepanova, Tamara
Kulchavenya, Ekaterina
Cek, Mete
Wagenlehner, Florian
Johansen, Truls Erik Bjerklund
,
Clinical trials referenced in this document:
Documents that mention this clinical trial
Urosepsis 30-day mortality, morbidity, and their risk factors: SERPENS study, a prospective, observational multi-center study
https://doi.org/10.1007/s00345-024-04979-2
Funding for this research was provided by:
European Association of Urology Research Foundation
Article History
Received: 12 January 2024
Accepted: 5 April 2024
First Online: 10 May 2024
Declarations
:
: Authors declare that they have no conflict of interest in keeping with the current research and manuscript.
: This study was conducted in accordance with the principles outlined in the Declaration of Helsinki. Ethical approval for the research protocol was obtained from Justus Liebig University, Giessen, Germany ethical board (AZ: 77/14) on 15/05/2014. Confidentiality and privacy of participant data were strictly maintained, and all data were anonymized before analysis. The authors affirm their commitment to transparency, accuracy, and ethical conduct throughout the research process.